Results 211 to 220 of about 7,364,456 (335)

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Methods used to develop quality of care standards and indicators for mental health across the WHO European region: a rapid systematic review. [PDF]

BMJ Open Qual
Hall J, Sibilio R, Lazeri L, Breda J.
europepmc   +1 more source

Towards Standard M2M APIs for Cloud-based Telco Service Platforms

, 2013
Asma Elmangoush, Adel Al-Hezmi, Thomas Magedanz   +2 more
openalex   +2 more sources

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Revised professional standards: guidance [PDF]

, 2011

core  

Strengthening digital health systems in the Pacific: The need for interoperability and innovation. [PDF]

Digit Health
Maua RF, Oli K, Kafoa B, Win Tin ST.
europepmc   +1 more source

The Jewel Wasp Standard Brain: Average shape atlas and morphology of the female Nasonia vitripennis brain

, 2019
Jitte Groothuis, Keram Pfeiffer, Basil el Jundi, Hans M. Smid   +3 more
openalex   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Exploring reference standards for the measurement of respiratory rate in children under 5 years of age: a scoping review. [PDF]

BMJ Paediatr Open
Tzirita S, King C, McCollum ED, Baker K, Bordallo López M, Schedwin M.   +5 more
europepmc   +1 more source

A randomized trial of high‐dose interferon alpha‐2b, with or without ribavirin, in chronic hepatitis C patients who have not responded to standard dose interferon [PDF]

, 2002
A. H. Malik, K. Shiva Kumar, Peter F. Malet, George Ostapowicz, Glenn A. Adams, Michael Wood, Karen Yarbrough, Alex R. Jones, W. M. Lee   +8 more
openalex   +1 more source